CCR5-and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue

Nature Medicine

Volumn 5, Issue 3, 1999, Pages 344-346

  Grivel, Jean Charles ^a   Margolis, Leonid B ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 120;

ARTICLE; CYTOTOXICITY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOPATHOGENIC EFFECT, VIRAL; HIV-1; HUMANS; LYMPHOID TISSUE; MICE; MICE, SCID; RECEPTORS, CCR5; RECEPTORS, CXCR4;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033011115     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/6565     Document Type: Article

References (15)

1. Tersmette, M. et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1, 983-985 (1989).
2. Scarlatti, C. et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Med. 3, 1259-1265 (1997).
3. Berger, E.A. HIV entry and tropism: the chemokine receptor connection. AIDS 11, S3-S16 (1997).
4. Glushakova, S., Baibakov, B., Margolis, L.B. & Zimmerberg, J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nature Med. 1, 1320-1322 (1995).
5. Glushakova, S. et al. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nature Med. 4, 346-349 (1998).
6. Picchio, G.R., Gulizia, R.J., Wehrly, K., Chesebro, B. & Mosier, D.E. The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. J. Virol. 72, 2002-2009 (1998).
7. Penn, M.L., Grivel, J.-C, Shramm, B., Godsmith, M.A. & Margolis, L.B. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1 - infected human lymphoid tissue. Proc. Natl. Acad. Sci. USA 96, 663-668 (1999)
8. Bleul, C.C., Wu, L., Hoxie, J.A., Springer, T.A. & Mackay, C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1930 (1997).
9. Zaitseva, M. et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature Med. 3, 1369-1375 (1997).
10. Glushakova, S., Baibakov, B., Zimmerberg, J. & Margolis, L. Experimental HIV infection of human lymphoid tissue: Correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histoculture inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res. Retroviruses 13, 461-471 (1997).
11. Haase, A.T. et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274, 985-989 (1996).
12. Casella, C.R. & Finkel, T.H. Mechanisms of lymphocyte killing by HIV. Curr. Opin. Hematol. 4, 24-31 (1997).
13. Bjorndal, A. et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478-7487 (1997).
14. Herbein, G. et al. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395, 189-194 (1998).
15. McDermott, D.H. et al. CCR5 promoter polymorphism and HIV-1 disease progression. Lancet 352, 866-870 (1998).